Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2003
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm
08/06/2003CN1434726A Multivalent platform molecules comprising high molecular weight polyethylene oxide
08/06/2003CN1434725A Amphiphilic polymers and polypeptide conjugates comprising same
08/06/2003CN1434713A Sustained-release formulation of a cyclooxygenase-2 inhibitor
08/06/2003CN1434706A Compounds and methods for modulating cerebral anyloid angiopathy
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose
08/06/2003CN1434703A Delayed release compositions and combinations
08/06/2003CN1434701A Y-IFN liquid-droplet aerosol and method
08/06/2003CN1434697A Hair growth stimulant compositions with sustained action
08/06/2003CN1434691A Tissue sensitizing compounds for females and methods and apparatus for the delivery of these compounds
08/06/2003CN1433775A Long-ncting heparin intraocular slow-released system
08/06/2003CN1433755A Long-acting tretnoin intraocular slow-releasing system
08/06/2003CN1116901C Powdery pharmaceutical preparation and method of manufacturing same
08/06/2003CN1116900C Solubilizing agent and external preparation containing the same
08/06/2003CN1116897C Parathyroid hormone medicine coposition
08/06/2003CN1116875C Taxual-lipid composition and its preparing process
08/06/2003CN1116874C TPA injection and its producing technology
08/06/2003CN1116865C Use of crosslinked cation polymer in skin cosmetics and skin disease preparations
08/05/2003US6603014 Use of cyclic enamines as light protection agents
08/05/2003US6602995 The reaction product of an alkali cellulose with a hydroxypropylating agent is granulated and the resulting granular material is neutralized with acid
08/05/2003US6602991 Solution composed of sodium chloride, monobasic and dibasic sodium phosphate dissolved in water; agitation, filtering and drying; use in the treatment for cholera and as antidote for ferrous ion intoxication
08/05/2003US6602988 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects
08/05/2003US6602981 Antinociceptive agent derivative
08/05/2003US6602975 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
08/05/2003US6602952 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers
08/05/2003US6602915 Therapeutic azo-compounds for drug delivery
08/05/2003US6602902 Dha-pharmaceutical agent conjugates to improve tissue selectivity
08/05/2003US6602882 Quinoline derivatives and their use as antibacterial agents
08/05/2003US6602860 Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds
08/05/2003US6602854 Branched multimeric Apo A-I agonist compounds
08/05/2003US6602672 Nucleic acid sequence; assay for distinguishing between conformational shapes and isolating infectious and noninfectious prions; neurodegenerative diseases; transgenic animals
08/05/2003US6602523 Adsorbed on surface of inorganic core selected from noble metals, metal oxides, metal nitrides, metal carbides, metal phosphates, metal carbonates, metal sulfates, metal halides, carbonaceous materials, ceramics, zeolites, SiO2; high surface
08/05/2003US6602511 Lecithin, sphingolipid or galacto lipid hydrophobic surfactant and hydrophilic surfactant; oil in water emulsion; administering low water soluble drugs
08/05/2003US6602508 Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine
08/05/2003US6602502 Improved immunoassays of psychotomimetic drugs, narcotic drugs, tetrahydrocannabinols; use of the haptenic properties of psychoactive material; blood test N,N-Dimethyltryptamine and 5-Methoxy-N,N- Dimethyltryptamine
08/05/2003US6602499 Viral mutants for selectively killing neoplastic cells; herpes simplex virus vector; transgene encoding cytochrome P450, chemotherapeutic agent activated by cytochrome P450; viral mediated oncolysis and anticancer "suicide" gene therapy
08/05/2003US6602498 Water soluble polymer backbone such as polyethylene glycol, endcapped with a N-maleimidyl moiety without using a linker; conjugated peptides, proteins, nucleotides and drugs
08/05/2003US6602274 Targeted transcutaneous cancer therapy
08/05/2003US6602269 Embolic devices capable of in-situ reinforcement
08/05/2003CA2329259C Convection-enhanced delivery of aav vectors
08/05/2003CA2246730C Confections containing sweetener
08/05/2003CA2224412C Composition containing a nerve fibre reactivity modulating compound
08/05/2003CA2115943C Novel process for the preparation of cetrorelix lyophilisate
08/05/2003CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
07/2003
07/31/2003WO2003062819A2 Water- soluble derivatives of lipophilic drugs
07/31/2003WO2003062401A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
07/31/2003WO2003062372A2 Nanoparticle assembled hollow spheres
07/31/2003WO2003062369A2 Expansion of renewable stem cell populations
07/31/2003WO2003062368A1 Method for producing a water-alcohol solution and products based thereon
07/31/2003WO2003062342A1 Pressure-sensitive adhesive and patch employing the same
07/31/2003WO2003062290A1 Polymer conjugates
07/31/2003WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies
07/31/2003WO2003062198A1 Integrin targeted imaging agents
07/31/2003WO2003062182A1 Method for stabilizing reduced coenzyme q10 and composition therefor
07/31/2003WO2003061816A1 Apparatus and process for preparing crystalline particles
07/31/2003WO2003061757A1 Transdermal/transmucosal preparations for electroporation
07/31/2003WO2003061728A2 Oral administration of interferon-tau
07/31/2003WO2003061721A1 Film-forming compositions and methods
07/31/2003WO2003061719A1 Process for production of pressure-sensitive adhesive moldings comprising crosslinked polymers as the main component
07/31/2003WO2003061713A1 Nsaid-containing topical formulations that demonstrate chemopreventive activity
07/31/2003WO2003061709A1 A method for preparing resinates
07/31/2003WO2003061708A1 Stabilized formulations of adenovirus
07/31/2003WO2003061707A1 Dermatological water-resistant compositions with sun screens and method for production and use of such compositions
07/31/2003WO2003061706A1 A weight management system for obese animals
07/31/2003WO2003061705A1 Weight management system for obese animals
07/31/2003WO2003061699A1 Remedies for allergic diseases
07/31/2003WO2003061694A1 Immunosuppression of the humoral immune response by anti-cd20 antibodies
07/31/2003WO2003061691A1 Orodispersible pharmaceutical composition comprising perindopril
07/31/2003WO2003061690A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
07/31/2003WO2003061689A1 Thrombin derived peptides for promoting cardiac tissue repair
07/31/2003WO2003061687A1 High-concentration preparation of soluble thrombomodulin
07/31/2003WO2003061667A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003WO2003061666A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
07/31/2003WO2003061662A1 Orodispersible pharmaceutical composition comprising ivabradine
07/31/2003WO2003061661A1 Orally dispersible pharmaceutical piribedil composition
07/31/2003WO2003061646A1 Process for producing granules containing branched amino acids
07/31/2003WO2003061644A1 Orodispersible pharmaceutical composition comprising agomelatine
07/31/2003WO2003061642A1 Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias
07/31/2003WO2003061636A2 Dna dosage forms
07/31/2003WO2003061634A1 Sustained release pharmaceutical composition
07/31/2003WO2003061633A1 Non-gelatin capsule shell formulation comprising iota-carrageenan and kappa-carrageenan
07/31/2003WO2003061632A1 Method of treatment of a patient requiring analgesia
07/31/2003WO2003061629A2 Dna dosage forms
07/31/2003WO2003061626A1 Polymeric gel system for the controlled delivery of codrugs
07/31/2003WO2003061623A1 Solid orally-dispersible pharmaceutical formulation
07/31/2003WO2003061621A2 Dermal application system for aminolevulinic acid-derivatives
07/31/2003WO2003061620A2 Peptide-carrying bodies for immune response
07/31/2003WO2003061608A1 Water-in-oil emulsion composition and emulsion cosmetic comprising the same
07/31/2003WO2003061593A2 Novel targeted compositions for diagnostic and therapeutic use
07/31/2003WO2003061584A2 Novel substituted benzimidazole dosage forms and method of using same
07/31/2003WO2003061577A2 Polyalkylene glycol with moiety for conjugating biologically active compound
07/31/2003WO2003061568A2 Methods and therapeutic compositions in the treatment of advanced cancer
07/31/2003WO2003061559A2 Binding peptides specific for the extracellular domain of erbb2 and uses therefor
07/31/2003WO2003061554A2 Composition containing moutan root bark extract as active ingredient
07/31/2003WO2003061402A2 Reduction of renal damage in companion animals
07/31/2003WO2003061389A1 Antiseptic compositions and methods
07/31/2003WO2003061362A2 Methods and compositions for treating polycystic ovary syndrome
07/31/2003WO2003034988A3 Injectable compositions for the controlled delivery of pharmacologically active compound
1 ... 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 ... 1712